Profound Medical (PROF)
Commercializes MRI-guided ultrasound platforms for prostate ablation and focused-ultrasound treatment.
$6.83
At close+0.03 (+0.44%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions61 holders · as of Mar 31, 2026 | 44.72% | 16.34M shares | |
| Insiders1 holder · as of May 20, 2025 | 1.61% | 587.1K shares | |
| Otherremainder | 53.67% | 19.61M shares |
36.53M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
61 holders · 16.34M shares · 11 new positions · 32 increased · 7 reduced · 16 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FIL Ltd | 2.34M | 6.41% | +140.0K | May 15, 2026 |
| Gagnon Securities LLC | 1.94M | 5.32% | +263 | Apr 22, 2026 |
| Royce & Associates LP | 1.12M | 3.06% | +126.0K | May 12, 2026 |
| Timelo Investment Management Inc. | 1.11M | 3.05% | +135.0K | May 14, 2026 |
| Gagnon Advisors, LLC | 962.2K | 2.63% | 0 | Apr 22, 2026 |
| Letko, Brosseau & Associates Inc | 953.2K | 2.61% | −17.5K | May 12, 2026 |
| Rosalind Advisors, Inc. | 828.1K | 2.27% | −240.8K | May 14, 2026 |
| Z3 Capital Partners, LLC | 818.0K | 2.24% | −950 | May 7, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Gagnon Securities LLC | 6.40% | 1.92M | 13G | Jan 23, 2025 ↗ |
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.